Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 75330-75-5 | Product Number: L0214
Lovastatin
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- Mevinolin
- 6α-Methylcompactin
- Monacolin K
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 5G |
£57.00
|
3 | ≥100 |
|
| 25G |
£191.00
|
2 | ≥40 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | L0214 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__4H__3__6O__5 = 404.55 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Condition to Avoid | Light Sensitive |
| CAS RN | 75330-75-5 |
| Reaxys Registry Number | 4720754 |
| PubChem Substance ID | 87560159 |
| Merck Index (14) | 5586 |
| MDL Number | MFCD00072164 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 166.0 to 170.0 °C |
| Specific rotation [a]20/D | +320 to +340 deg(C=0.5, CH3CN) |
Properties (reference)
| Melting Point | 179 °C |
| Specific Rotation | 320° (C=0.5,CH3CN) |
| Solubility in water | Insoluble |
| Degree of solubility in water | 0.4 mg/l 25 °C |
| Solubility (soluble in) | Ethanol, Methanol |
GHS
| Hazard Statements | H413 : May cause long lasting harmful effects to aquatic life. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. |
Related Laws:
| RTECS# | EK7907000 |
Transport Information:
| HS Number | 2932990090 |
Application
Lovastatin: A Potent HMG-CoA Reductase Inhibitor
Lovastatin is a potent 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor. It was first isolated from in a fermentation broth of Aspergillus terreus in 1978, and taken into clinical development as potential agents for lowering LDL cholesterol. Lovastatin is an inactive lactone which is readily hydrolyzed in vivo to the corresponding active beta-hydroxy acid. The active acid inhibits the action of enzyme HMG-CoA reductase that catalyzes the rate-limiting step in cholesterol biosynthesis, resulting in the reduction of low-density-lipoprotein (LDL) and total cholesterol levels. (The product is for research purpose only.)
References
- Case history: Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors (a review)
- Analysis of 5 HMG-CoA reductase inhibitors-atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies
- Chromatography-mass spectrometry methods for the quantitation of statins in biological samples (a review)
- Solubility of lovastatin in a family of six alcohols: ethanol, 1-propanol, 1-butanol, 1-pentanol, 1-hexanol, and 1-octanol
Application
HMG-CoA Reductase Inhibitors (Statins)
Lovastatin is a potent 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor. It was first isolated from in a fermentation broth of Aspergillus terreus in 1978, and taken into clinical development as potential agents for lowering LDL cholesterol. Lovastatin is an inactive lactone which is readily hydrolyzed in vivo to the corresponding active beta-hydroxy acid. The active acid inhibits the action of enzyme HMG-CoA reductase that catalyzes the rate-limiting step in cholesterol biosynthesis, resulting in the reduction of low-density-lipoprotein (LDL) and total cholesterol levels. (The product is for research purpose only.)
References
- Case history: Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors (a review)
- Analysis of 5 HMG-CoA reductase inhibitors-atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies
- Chromatography-mass spectrometry methods for the quantitation of statins in biological samples (a review)
- Solubility of lovastatin in a family of six alcohols: ethanol, 1-propanol, 1-butanol, 1-pentanol, 1-hexanol, and 1-octanol
PubMed Literature
Articles/Brochures
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.